Exact Mass: 298.1681

Exact Mass Matches: 298.1681

Found 61 metabolites which its exact mass value is equals to given mass value 298.1681, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Fumigaclavine A

4,6-Dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetic acid

C18H22N2O2 (298.1681)


Fumigaclavine A is an alkaloid from Aspergillus fumigatu Fumigaclavine A. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6879-59-0 (retrieved 2024-08-26) (CAS RN: 6879-59-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus. 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is an alkaloid from peelings of Citrus unshiu (satsuma mandarin). Alkaloid from peelings of Citrus unshiu (satsuma mandarin). 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus.

   

Carazolol

1-(9H-carbazol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

C18H22N2O2 (298.1681)


   

Carazolol

Carazolol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

Maybridge3_002255

Maybridge3_002255

C18H22N2O2 (298.1681)


   

Methoxydoisuthine

Methoxydoisuthine

C18H22N2O2 (298.1681)


   

Strychnochromine

Strychnochromine

C18H22N2O2 (298.1681)


   
   

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

C18H22N2O2 (298.1681)


   

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

C18H22N2O2 (298.1681)


   

dehydroodorin|Dehydroodorine

dehydroodorin|Dehydroodorine

C18H22N2O2 (298.1681)


   

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

C18H22N2O2 (298.1681)


   

Roquefortine A

Roquefortine A

C18H22N2O2 (298.1681)


CONFIDENCE isolated standard

   

Fumigaclavine A

4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


An ergot alkaloid produced by the fungus Aspergillus fumigatus that is ergoline which is substituted by methyl groups at the 6 and 8beta positions, and by an acetoxy group at the 9beta position.

   

N,a',N',a-Cyclodi(4-methylaminobenzeneethanol)

2,9-dimethyl-2,9-diazatricyclo[10.2.2.2^{5,8}]octadeca-1(14),5,7,12,15,17-hexaene-3,10-diol

C18H22N2O2 (298.1681)


   

1-(4-AMINOPHENYL)METHANESULFONAMIDE

1-(4-AMINOPHENYL)METHANESULFONAMIDE

C18H22N2O2 (298.1681)


   

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

C18H22N2O2 (298.1681)


   

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

C18H22N2O2 (298.1681)


   

Phenacaine

holocalin(p)

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

C18H22N2O2 (298.1681)


   

1-Diphenylmethylazetidin-3-amine acetate

1-Diphenylmethylazetidin-3-amine acetate

C18H22N2O2 (298.1681)


   

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

C18H22N2O2 (298.1681)


   

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

C18H22N2O2 (298.1681)


   

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

C18H22N2O2 (298.1681)


   

(-)-BIS[(S)-1-PHENYLETHYL]AMINEHYDROCHLORIDE

(2s)-1-(9h-Carbazol-4-Yloxy)-3-(Isopropylamino)propan-2-Ol

C18H22N2O2 (298.1681)


   

(+)-B-HYDRASTINEHCL

(+)-B-HYDRASTINEHCL

C18H22N2O2 (298.1681)


   

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

C18H22N2O2 (298.1681)


   

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

C18H22N2O2 (298.1681)


   

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

C18H22N2O2 (298.1681)


   

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

C18H22N2O2 (298.1681)


   

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

C18H22N2O2 (298.1681)


   

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

C18H22N2O2 (298.1681)


   

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

C18H22N2O2 (298.1681)


   

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

C18H22N2O2 (298.1681)


   

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

C18H22N2O2 (298.1681)


   

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

C18H22N2O2 (298.1681)


   

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

C18H22N2O2 (298.1681)


   

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


   

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

C18H22N2O2 (298.1681)


   

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O2 (298.1681)


   

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)